MktsMarkets

Bio-Rad Laboratories, Inc.
NYSE: BIOKey statistics
BIO News
Stories mentioning BIO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 592,100 | 693,200 | 653,000 | 651,600 | 585,400 | 649,700 | 638,500 | |
| Cost of Goods Sold | 282,700 | 348,000 | 309,600 | 306,300 | 279,400 | 293,800 | 283,400 | |
| Gross Profit | 309,400 | 345,200 | 343,400 | 345,300 | 306,000 | 342,000 | 355,900 | 355,100 |
| Operating Expenses | ||||||||
| Research & Development | 62,900 | 70,300 | 71,300 | 60,500 | 73,500 | 79,600 | 91,000 | 58,900 |
| Sales General & Admin | 212,400 | 221,000 | 206,800 | 207,700 | 208,800 | 204,000 | 200,400 | 194,700 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 34,100 | (118,900) | 65,300 | 77,100 | 23,700 | 58,400 | 64,500 | 101,500 |
| Interest Income | ||||||||
| Interest Expense | 12,300 | 12,100 | 12,300 | 12,600 | 12,000 | 12,200 | 12,100 | 12,300 |
| Other Expense | 24,200 | 28,600 | 8,300 | 16,200 | 37,200 | 19,600 | 17,900 | 18,200 |
| Pretax Income | (689,800) | 929,200 | (431,100) | 414,000 | 83,400 | (908,900) | 861,600 | (2,786,300) |
| Tax Provision | (162,700) | 209,200 | (89,200) | 96,200 | 19,400 | (193,100) | 208,400 | (620,800) |
| Net Income (Loss) | (527,100) | 720,000 | (341,900) | 317,800 | 64,000 | (715,800) | 653,200 | (2,165,500) |
| Earnings Per Share (Basic) | (19.55) | 26.41 | (12.70) | 11.67 | 2.29 | (25.57) | 23.37 | (76.26) |
| Earnings Per Share (Diluted) | (19.55) | 26.39 | (12.70) | 11.67 | 2.29 | (25.57) | 23.34 | (76.26) |
| Weighted Average Shares Outstanding (Basic) | 26,958 | 27,263 | 26,923 | 27,226 | 27,941 | 28,214 | 27,949 | 28,395 |
| Weighted Average Shares Outstanding (Diluted) | 26,958 | 27,281 | 26,923 | 27,228 | 27,955 | 28,214 | 27,985 | 28,395 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BIO
Bio-Rad Laboratories, Inc. (NYSE: BIO) is a stock listed on the New York Stock Exchange under the ticker symbol BIO. It last traded at $368.82 (Nov 18, 2026, 2:07 PM ET), up 3.0% on the day. That gives Bio-Rad Laboratories a market capitalisation of $9.7B and a price-to-earnings ratio of 9.5.
Over the past 52 weeks BIO has traded between $236.73 and $396.23.
Revenue for the quarter ended Mar 31, 2026 was $592.1M; a net loss of $527.1M. Revenue was up 1.1% from $585.4M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $592.1M | -$527.1M | -89.0% |
| Dec 31, 2025 | $693.2M | $720.0M | 103.9% |
| Sep 30, 2025 | $653.0M | -$341.9M | -52.4% |
| Jun 30, 2025 | $651.6M | $317.8M | 48.8% |
From Bio-Rad Laboratories’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…